Results 111 to 120 of about 194,403 (293)

Bioinformatics identifies key genes and potential drugs for energy metabolism disorders in heart failure with dilated cardiomyopathy

open access: yesFrontiers in Pharmacology
Background: Dysfunction in myocardial energy metabolism plays a vital role in the pathological process of Dilated Cardiomyopathy (DCM). However, the precise mechanisms remain unclear.
Haixia Wang   +9 more
doaj   +1 more source

Dilated Cardiomyopathy [PDF]

open access: yesCirculation: Arrhythmia and Electrophysiology, 2013
Neal K, Lakdawala   +2 more
openaire   +2 more sources

Dilated Cardiomyopathy in dogs- A review

open access: yes, 2022
Dilated cardiomyopathy is sudden onset most common cardiac disease in large breed dogs that results in progressive heart muscles dysfunction and congestive heart failure or death in dogs. Its affects middle and older age dogs.
Yogendra Kumar Meena   +2 more
core   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos   +4 more
wiley   +1 more source

Cardiovascular Immunology Research in Wuhan Union Hospital: Over the Past 25 years

open access: yesCardiovascular Innovations and Applications, 2017
Cardiovascular immunology research in Wuhan Union Hospital began in 1991. Anti-heart antibodies in dilated cardiomyopathy and acute viral myocarditis began to be reported from 1993.
Yuhua Liao, Yiyi Wang
doaj   +1 more source

Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu   +9 more
wiley   +1 more source

Dilated cardiomyopathy due to novel LMNA mutation: a case report

open access: yesFrontiers in Cardiovascular Medicine
A case of a 44-year-old man presenting with a family history of LMNA mutation and cardiac symptoms (dizziness, weakness, palpitations, and shortness of breath) congruent with dilated cardiomyopathy.
Riddhi Patel   +3 more
doaj   +1 more source

FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1485-1489, April 2025.
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran   +10 more
wiley   +1 more source

Tafazzin gene mutations are uncommon causes of dilated cardiomyopathy in adults

open access: yesCardiogenetics, 2011
Barth syndrome is an X-linked genetic condition featuring neutropenia, skeletal myopathy, and dilated cardiomyopathy in boys due to tafazzin (TAZ) mutations.
Matthew Taylor   +8 more
doaj   +1 more source

Cardiovascular: Congestive (Dilated) Cardiomyopathy (Transplant Native Heart)

open access: yes, 1900
Congestive (dilated) cardiomyopathy. (Transplant Native Heart)
MUSC Department of Pathology and Laboratory Medicine
core  

Home - About - Disclaimer - Privacy